Axsome Therapeutics announces full exercise of underwriter's option
Axsome Therapeutics announced underwriter of the Company's public offering has exercised in full its option to purchase an additional 561,497 shares. Total gross proceeds of an aggregate 4,304,813 shares at a price to the public of $3.74 per share are $16.1 million. March 29, 2017